BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32187034)

  • 1. Higher visit-to-visit blood pressure variability and N-terminal pro-brain natriuretic peptide elevation: influence of left ventricular hypertrophy and left ventricular diastolic function.
    Takahari K; Nagai M
    Blood Press Monit; 2020 Jun; 25(3):126-130. PubMed ID: 32187034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.
    Kim SW; Park SW; Lim SH; Kwon SU; Choi YJ; Park MK; Lee SC; Lee SH; Park JE; Jeon ES
    Clin Cardiol; 2006 Apr; 29(4):155-60. PubMed ID: 16649724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients.
    Ceyhan C; Unal S; Yenisey C; Tekten T; Ceyhan FB
    Int J Cardiovasc Imaging; 2008 Mar; 24(3):253-9. PubMed ID: 17687631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
    Tuğcu A; Yildirimtürk O; Aytekin S
    Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction.
    Islam MN; Chowdhury MS; Paul GK; Debnath RC; Shakil SS
    Mymensingh Med J; 2019 Apr; 28(2):333-346. PubMed ID: 31086148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
    Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
    Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study.
    Nah EH; Kim SY; Cho S; Kim S; Cho HI
    BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients.
    Yamazaki M; Ogawa T; Tamei N; Ando Y; Nitta K
    Heart Vessels; 2011 Jul; 26(4):421-7. PubMed ID: 21127887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
    Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide and diastolic function measurements by adenosine stress echocardiography in prediction of coronary stenosis in patients.
    Zheng P; Wang H; Tian YQ; Guo YL; He ZX; Lu Y; Zheng X; Ma WJ; Xu N; Sun X; Zhang L
    Chin Med J (Engl); 2011 Jul; 124(14):2089-95. PubMed ID: 21933607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triphasic mitral inflow velocity with mid-diastolic flow: the presence of mid-diastolic mitral annular velocity indicates advanced diastolic dysfunction.
    Ha JW; Ahn JA; Moon JY; Suh HS; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Eur J Echocardiogr; 2006 Jan; 7(1):16-21. PubMed ID: 16378917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide levels and abnormal geometric patterns of left ventricle in untreated hypertensive patients.
    Elbasan Z; Gür M; Sahin DY; Kırım S; Akyol S; Kuloğlu O; Koyunsever NY; Seker T; Kıvrak A; Caylı M
    Clin Exp Hypertens; 2014; 36(3):153-8. PubMed ID: 23848978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.
    Lee JA; Kim DH; Yoo SJ; Oh DJ; Yu SH; Kang ET
    Perit Dial Int; 2006; 26(3):360-5. PubMed ID: 16722030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial.
    Kusunose K; Imai T; Tanaka A; Dohi K; Shiina K; Yamada T; Kida K; Eguchi K; Teragawa H; Takeishi Y; Ohte N; Yamada H; Sata M; Node K;
    Cardiovasc Diabetol; 2021 Sep; 20(1):186. PubMed ID: 34521417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis.
    Hildebrandt P; Boesen M; Olsen M; Wachtell K; Groenning B
    Eur J Heart Fail; 2004 Mar; 6(3):313-7. PubMed ID: 14987582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.